CoChat
Sign Up
Cited by 80

The DOI matches its Crossref record.

Oxidized cholesteryl esters and inflammation

Choi, Soo-Ho, Sviridov, Dmitri, Miller, Yury I.·2017·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
DOI 10.1016/j.bbalip.2016.06.020PMC PMC5199681
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbalip.2016.06.020

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 47

  1. Steinberg, 1989, Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity, N. Engl. J. Med., 320, 915
  2. Steinberg, 2009, The LDL modification hypothesis of atherogenesis: an update, J. Lipid Res., 50, S376, 10.1194/jlr.R800087-JLR200 · DOI
  3. Milman, 2008, Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial, Arterioscler. Thromb. Vasc. Biol., 28, 341, 10.1161/ATVBAHA.107.153965 · DOI
  4. Boaz, 2000, Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial, Lancet, 356, 1213, 10.1016/S0140-6736(00)02783-5 · DOI
  5. Kris-Etherton, 2004, Antioxidant vitamin supplements and cardiovascular disease, Circulation, 110, 637, 10.1161/01.CIR.0000137822.39831.F1 · DOI
  6. Miller, 2011, Oxidation-specific epitopes are danger associated molecular patterns recognized by pattern recognition receptors of innate immunity, Circ. Res., 108, 235, 10.1161/CIRCRESAHA.110.223875 · DOI
  7. van Dijk, 2012, Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions, J. Lipid Res., 53, 2773, 10.1194/jlr.P030890 · DOI
  8. Lee, 2012, Role of phospholipid oxidation products in atherosclerosis, Circ. Res., 111, 778, 10.1161/CIRCRESAHA.111.256859 · DOI
  9. Leibundgut, 2013, Oxidation-specific epitopes and immunological responses: translational biotheranostic implications for atherosclerosis, Curr. Opin. Pharmacol., 13, 168, 10.1016/j.coph.2013.02.005 · DOI
  10. Kadl, 2011, Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2, Free Radic. Biol. Med., 51, 1903, 10.1016/j.freeradbiomed.2011.08.026 · DOI
  11. Rao, 2014, CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure, Circ. Res., 115, 770, 10.1161/CIRCRESAHA.115.304666 · DOI
  12. Oh, 2016, Oxidized LDL signals through Rho-GTPase to induce endothelial cell stiffening and promote capillary formation, J. Lipid Res., 57, 791, 10.1194/jlr.M062539 · DOI
  13. Colles, 2001, Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols, Trends Cardiovasc. Med., 11, 131, 10.1016/S1050-1738(01)00106-2 · DOI
  14. Tsimikas, 2011, Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease, Curr. Pharm. Des., 17, 27, 10.2174/138161211795049831 · DOI
  15. Miller, 2010, Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis, Subcell. Biochem., 51, 229, 10.1007/978-90-481-8622-8_8 · DOI
  16. Belkner, 1998, The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E, J. Biol. Chem., 273, 23225, 10.1074/jbc.273.36.23225 · DOI
  17. Hutchins, 2012, Cholesteryl ester acyl oxidation and remodeling in murine macrophages: formation of oxidized phosphatidylcholine, J. Lipid Res., 53, 1588, 10.1194/jlr.M026799 · DOI
  18. Yin, 2002, Formation of isoprostane bicyclic endoperoxides from the autoxidation of cholesteryl arachidonate, J. Am. Chem. Soc., 124, 7745, 10.1021/ja0201092 · DOI
  19. Yin, 2004, Identification of a novel class of endoperoxides from arachidonate autoxidation, J. Biol. Chem., 279, 3766, 10.1074/jbc.M307137200 · DOI
  20. Folcik, 1994, Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDL, J. Lipid Res., 35, 1570, 10.1016/S0022-2275(20)41155-1 · DOI
  21. Hoppe, 1997, Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions, J. Lipid Res., 38, 1347, 10.1016/S0022-2275(20)37418-6 · DOI
  22. Chancharme, 1999, Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL, Arterioscler. Thromb. Vasc. Biol., 19, 810, 10.1161/01.ATV.19.3.810 · DOI
  23. Suarna, 1995, Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate, Arterioscler. Thromb. Vasc. Biol., 15, 1616, 10.1161/01.ATV.15.10.1616 · DOI
  24. Upston, 2002, Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis, Am. J. Pathol., 160, 701, 10.1016/S0002-9440(10)64890-0 · DOI
  25. Hutchins, 2011, Electrospray tandem mass spectrometry reveals extensive and non-specific oxidation of cholesterol esters in human peripheral vascular lesions, J. Lipid Res., 52, 2070, 10.1194/jlr.M019174 · DOI
  26. Ravandi, 2014, Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans, J. Am. Coll. Cardiol., 63, 1961, 10.1016/j.jacc.2014.01.055 · DOI
  27. Choi, 2013, Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages, PLoS One, 8, 10.1371/journal.pone.0083145 · DOI
  28. Harkewicz, 2008, Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized LDL, J. Biol. Chem., 283, 10241, 10.1074/jbc.M709006200 · DOI
  29. Kawai, 2003, Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis, J. Biol. Chem., 278, 21040, 10.1074/jbc.M212426200 · DOI
  30. Van Heek, 1998, Cholesteryl hydroperoxyoctadecadienoate from oxidized low density lipoprotein inactivates platelet-derived growth factor, J. Biol. Chem., 273, 19405, 10.1074/jbc.273.31.19405 · DOI
  31. Huber, 2002, Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway, Arterioscler. Thromb. Vasc. Biol., 22, 581, 10.1161/01.ATV.0000012782.59850.41 · DOI
  32. Gargiulo, 2009, The core-aldehyde 9-oxononanoyl cholesterol increases the level of transforming growth factor beta1-specific receptors on promonocytic U937 cell membranes, Aging Cell, 8, 77, 10.1111/j.1474-9726.2009.00454.x · DOI
  33. Jedidi, 2006, Cholesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPAR[alpha], Biochem. Biophys. Res. Commun., 351, 733, 10.1016/j.bbrc.2006.10.122 · DOI
  34. Christison, 1995, Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein, J. Lipid Res., 36, 2017, 10.1016/S0022-2275(20)41119-8 · DOI
  35. Fluiter, 1999, Scavenger receptor BI mediates the selective uptake of oxidized cholesterol esters by rat liver, J. Biol. Chem., 274, 8893, 10.1074/jbc.274.13.8893 · DOI
  36. Miller, 2003, Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells, J. Biol. Chem., 278, 1561, 10.1074/jbc.M209634200 · DOI
  37. Choi, 2009, Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake, Circ. Res., 104, 1355, 10.1161/CIRCRESAHA.108.192880 · DOI
  38. Bae, 2009, Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2, Circ. Res., 104, 210, 10.1161/CIRCRESAHA.108.181040 · DOI
  39. Wiesner, 2010, Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor {kappa}B and activator protein-1. Possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia, Circ. Res., 107, 56, 10.1161/CIRCRESAHA.110.218420 · DOI
  40. Choi, 2012, Spleen tyrosine kinase regulates AP-1 dependent transcriptional response to minimally oxidized LDL, PLoS One, 7
  41. Rankovic, 2016, Biased agonism: an emerging paradigm in GPCR drug discovery, Bioorg. Med. Chem. Lett., 26, 241, 10.1016/j.bmcl.2015.12.024 · DOI
  42. Anderson, 2016, Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery?, J. Leukoc. Biol., 99, 901, 10.1189/jlb.2MR0815-392R · DOI
  43. Park, 2009, The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex, Nature, 458, 1191, 10.1038/nature07830 · DOI
  44. Kim, 2007, Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran, Cell, 130, 906, 10.1016/j.cell.2007.08.002 · DOI
  45. Choi, 2016, MD-2 binds cholesterol, Biochem. Biophys. Res. Commun., 470, 877, 10.1016/j.bbrc.2016.01.126 · DOI
  46. Tissieres, 2008, Soluble MD-2 is an acute phase protein and an opsonin for gram-negative bacteria, Blood, 111, 2122, 10.1182/blood-2007-06-097782 · DOI
  47. Miller, 2013, Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics, Curr. Opin. Lipidol., 24, 426, 10.1097/MOL.0b013e328364e85a · DOI

Cited by

Sorted by citations

Metadata

Authors
Choi, S.-H., Sviridov, D., & Miller, Y. I.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Publisher
Elsevier BV
Published
2017-04
Volume
1862
Issue
4
Pages
393-397
ISSN
1388-1981
DOI
10.1016/j.bbalip.2016.06.020
PMC
PMC5199681
Cited by
80
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • American Heart Association
  • National Institutes of Health (SDG14710028)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review